theophylline

Poland

Drugs containing this active substance

  • BALADEX

    The medicine is used for the treatment and prevention of shortness of breath occurring in bronchial asthma, bronchitis, and chronic obstructive pulmonary disease (such as emphysema or chronic bronchitis).

    Form: syrup

    Active substance Dosage
    theophylline 50 mg/5 ml
    guaifenesin 30 mg/5 ml

    ATC: R03DA54

    Manufacturer: Aflofarm Farmacja Polska Limited

  • The medicinal product is used in the prevention and treatment of respiratory disorders caused by airway narrowing (bronchospasm) in bronchial asthma and chronic obstructive pulmonary disease.

    Form: capsules, hard modified release

    Active substance Dosage
    theophylline 200 mg

    ATC: R03DA04

    Manufacturer: Takeda GmbH

  • The medicine is used for the prevention and treatment of respiratory disorders caused by narrowing of the airways (bronchospasm) occurring in bronchial asthma and chronic obstructive pulmonary disease.

    Form: capsules, hard modified release

    Active substance Dosage
    theophylline 300 mg

    ATC: R03DA04

    Manufacturer: Takeda GmbH

  • The medicine is used for the symptomatic treatment of respiratory problems, such as shortness of breath, wheezing, cough, asthma, chronic bronchitis, emphysema, or acute asthma attacks. It works by relaxing and dilating the airways in the lungs.

    Form: solution for infusion

    Active substance Dosage
    theophylline 1.2 g

    ATC: R03DA04

    Manufacturer: Bieffe Medital S.p.A.

  • It is used to treat acute and severe bronchospasms in chronic respiratory diseases, such as bronchial asthma (including status asthmaticus) and chronic obstructive pulmonary disease.

    Form: solution for injection for infusion

    Active substance Dosage
    theophylline 20 mg/ml

    ATC: R03DA04

    Manufacturer: Gebro Pharma GmbH

  • The medicinal product is intended for the treatment of acute and severe bronchospasm in chronic respiratory diseases, such as bronchial asthma (including status asthmaticus) and chronic obstructive pulmonary disease.

    Form: solution for injection for infusion

    Active substance Dosage
    theophylline 20 mg/ml

    ATC: R03DA04

    Manufacturer: Gebro Pharma GmbH

  • The medicinal product is used to treat acute and severe bronchospasms occurring in chronic respiratory diseases, such as bronchial asthma (including status asthmaticus) and chronic obstructive pulmonary disease.

    Form: solution for injection for infusion

    Active substance Dosage
    theophylline 20 mg/ml

    ATC: R03DA04

    Manufacturer: Gebro Pharma GmbH

  • It is used in the treatment of acute and severe bronchospasms occurring in bronchial asthma and chronic obstructive pulmonary disease.

    Form: solution for injection for infusion

    Active substance Dosage
    theophylline 20 mg/ml

    ATC: R03DA04

    Manufacturer: Gebro Pharma GmbH

  • The medicine is used to prevent bronchospasms in bronchial asthma and chronic obstructive pulmonary disease.

    Form: tablets, film-coated, prolonged release

    Active substance Dosage
    theophylline 150 mg

    ATC: R03DA04

    Manufacturer: Biofarm Sp. z o.o.

  • The medicine is used to prevent bronchospasms in bronchial asthma and chronic obstructive pulmonary disease.

    Form: tablets, film-coated, prolonged release

    Active substance Dosage
    theophylline 300 mg

    ATC: R03DA04

    Manufacturer: Biofarm Sp. z o.o.